Clinical trials
Multicenter Study clinical trials
Below are recruiting multicenter study clinical trials, each written for real people, not researchers. We’re tracking 411 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07514052Recruiting
Predicting Response to Selinexor Treatment in Relapsed Multiple Myeloma
This study tests whether doctors can predict which patients with relapsed or hard-to-treat multiple myeloma will respond well to a drug called selinexor. Researchers will collect blood and bone marrow samples to identify markers that help personalize treatment decisions.
Taiyuan, ShanxiAges 18 years+ - NCT07608003Recruiting
MRI AI model study for midline brain tumors
This study uses artificial intelligence to analyze MRI scans of midline brain tumors (gliomas) to help predict how the disease may progress and improve treatment planning. Researchers are collecting data from multiple hospitals to teach an AI system to better understand these tumors.
Changsha, HunanAges Any age - NCT07644013Recruiting
Multiple System Atrophy Registry Study in China
This study is collecting information from patients with multiple system atrophy (a rare neurological condition affecting movement and body functions), Parkinson disease, and healthy volunteers to better understand these conditions. By participating, you help doctors learn more about how these diseases develop and progress.
Beijing, Beijing MunicipalityAges 40–75 - NCT07668453RecruitingPhase 2
Adebrelimab plus chemo for advanced bile duct cancer
This study tests adding the immunotherapy adebrelimab to standard chemotherapy (gemcitabine and nab-paclitaxel) as a first treatment for advanced biliary tract cancer that can't be removed by surgery. The goal is to see if this combination helps shrink tumors and improve outcomes.
Nanjing, JiangsuAges 18–75 - NCT07207031Enrolling by invitation
Kidney injury in ICU patients: a study
This study tracks how often kidney problems occur in ICU patients. By watching your kidney function during your stay, researchers hope to better understand and prevent kidney injury in critically ill people.
GhentAges 18 years+ - NCT06849362Enrolling by invitation
Optimizing immunotherapy for advanced colorectal cancer
This study looks at how well different combinations of immunotherapy drugs work for advanced colorectal cancer that is MSS or MSI-L or pMMR. It reviews past patient records to see which treatments help control the disease and slow its growth.
Changsha, HunanAges Any age - NCT06837402Enrolling by invitation
Non-invasive ventilation in Argentine ICUs: an observational study
This study looks at how non-invasive breathing support (like a mask or machine) is used in ICUs across Argentina. It helps doctors understand patterns of care so they can improve treatment for patients with breathing problems.
CABA, Buenos AiresAges 18 years+ - NCT06242613Enrolling by invitation
Robot vs. laparoscopic surgery for stomach cancer
This study compares robot-assisted surgery to standard laparoscopic surgery for people with stage Ib, II, or III stomach cancer. It aims to see which approach leads to better recovery and outcomes.
Las Palmas de Gran Canaria, Las PalmasAges 18 years+ - NCT05354596Recruiting
SBRT radiation trial for central lung tumors
This trial studies a focused, high-dose radiation treatment called SBRT for lung tumors that are hard to operate on, including very central tumors near major airways or organs. It may help people control tumor growth while limiting radiation exposure to nearby critical structures.
AalborgAges 18 years+ - NCT05642338Recruiting
Testing two sampling methods to monitor Barrett’s esophagus
This study compares two ways of taking tissue samples during endoscopy to check how Barrett’s esophagus is changing. The goal is to improve surveillance, especially for finding early precancer or early cancer changes.
Amsterdam, North HollandAges 18 years+ - NCT07478614Recruiting
Study of treatments for adenomyosis pain and heavy bleeding
This study follows people with adenomyosis to see which treatments work best for pain and heavy bleeding. It may help doctors find better ways to manage symptoms.
PotenzaAges 20–50 - NCT07481526Recruiting
Chronic kidney disease registry study
This study is collecting information from people with chronic kidney disease (CKD) to understand how the disease progresses over time. It does not test any new treatments, so you keep your usual care.
Anning, Yunnan - South RegionAges Any age - NCT06791161Enrolling by invitation
Adjuvant therapy study for BRCA1/2 positive breast cancer
This study tests if additional treatment after surgery helps prevent breast cancer from returning. It is for people with hormone receptor-positive, HER2-negative breast cancer who have a BRCA1 or BRCA2 gene mutation and a high risk of recurrence.
Beijing, Beijing MunicipalityAges 18–75 - NCT06212947Recruiting
An observational study for children with hypochondroplasia
This study observes children with hypochondroplasia to learn more about the condition. It does not involve any treatment—just monitoring and data collection to help future research.
Phoenix, ArizonaAges Up to 15 years - NCT05069441Recruiting
Predicting breathing trouble after removing a breathing tube
This study looks at patients who are ready to have their breathing tube removed and checks how to predict who might struggle after extubation. It’s observational, meaning your care won’t be changed—researchers are gathering information to improve future predictions.
ChongqingAges 18 years+ - NCT04348253Recruiting
Study of surgery for scapholunate ligament wrist instability
This study looks at people aged 18–60 who have ongoing, painful wrist instability from a fully torn scapholunate ligament. It may help improve surgical approaches by carefully selecting patients whose ligament tear is complete and causing measurable joint looseness.
AarhusAges 18–60 - NCT06085690Recruiting
Reducing bloodstream infections from ICU catheters
This study tests a new method to prevent infections from central lines (special IVs placed in large veins) in intensive care units. If you have a central line in place for more than 24 hours, this research may help improve your safety by finding better ways to avoid catheter-related bloodstream infections.
Shanghai, Shanghai MunicipalityAges Any age - NCT06727812RecruitingPhase 1
Testing a new targeted therapy for advanced solid tumors
This trial tests a new drug called HRS-6208 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and if it can help shrink or control the cancer.
Nanjing, JiangsuAges 18–75 - NCT06376136RecruitingPhase 1/Phase 2
Combination therapy for advanced HER2-positive cancers
This trial tests a new combination of two drugs, BAT8010 and BAT1006, for people with advanced solid tumors that have HER2 expression. It aims to see if this combination is safe and effective for those who have run out of standard treatment options.
Guangzhou, GuangdongAges 18 years+ - NCT06679244Recruiting
New surgery for upper stomach cancer
This trial tests a new surgical technique for patients with cancer in the upper part of the stomach or where the stomach meets the esophagus. It aims to see if the new approach is safe and effective for removing the tumor and nearby lymph nodes.
ShanghaiAges 18–80 - NCT07096219Enrolling by invitation
Catheter Ablation for Leaky Mitral Valve in Persistent Atrial Fibrillation
This trial tests if catheter ablation—a procedure to fix heart rhythm—can help people with a leaky mitral valve that is caused by atrial fibrillation (functional mitral regurgitation). If you have persistent atrial fibrillation and moderate leaky valve, you may benefit from this treatment.
Guangzhou, GuangdongAges 18–75 - NCT06668012Recruiting
Vaginal health study for premenopausal women
This study looks at changes in vaginal bacteria in women before menopause. It aims to understand why some women have higher vaginal pH and how it relates to symptoms.
BarcelonaAges 18–45 - NCT06839547Recruiting
Testing a new drug with radiation for advanced breast cancer brain tumors
This study looks at how well a new anti-tumor drug works when given along with radiation therapy for people whose advanced breast cancer has spread to the brain. It may help the radiation work better and control the cancer longer.
BeijingAges 18 years+ - NCT06877195Recruiting
Vein graft support mesh for bypass surgery
This trial tests a mesh wrap that supports the vein grafts used in bypass surgery. It may help those grafts stay open longer, especially for the right side of the heart.
Roma, RomaAges Any age
Hear when a new Multicenter Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for multicenter study?
- Yes. Clin2 currently lists 411 recruiting multicenter study studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a multicenter study trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a multicenter study trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.